Studied since the early 1990s for gut healing, tendon repair, and systemic recovery, BPC-157 has never been placed on the formal Category 1 list yet it has one of the most extensive safety records in the peptide literature
The agency stated that the companies promoted compounded versions of GLP-1 medications in ways that implied sameness with FDA approved drugs and obscured the source of the products, including through branding practices that suggested the telehealth firms themselves were the compounders
It introduces analyses for metabolite annotation, joint clustering, enrichment tests, spatial alignment, multimodal integration, visualization and seamless software interoperability
The latest TGA data shows it requested 3263 "wellness and beauty industries unapproved high risk therapeutic goods advertising" online and social media advertisements to be removed, which captures unlawful peptide advertising
Investigators like Dr
Retatrutide is not licensed in the UK and is only available through approved clinical trials